LEADER 01565oam  2200409 a 450 
001 9910701998203321
005 20120703094934.0
035   $a(CKB)5470000002422131
035   $a(OCoLC)340722270
035   $a(EXLCZ)995470000002422131
100   $a20090522d2004      ua             0
101 0 $aeng
135   $aurbn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $eindependent consultants for biotechnology clinical trial protocols
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research :$cCenter for Drug Evaluation and Research,$d[2004]
215   $a1 online resource (i, 4 pages)
300   $aTitle from title screen (viewed on May 22, 2009).
300   $a"August 2004".
517   $aGuidance for industry 
606   $aConsultants$xGovernment policy$zUnited States
606   $aClinical trials$xGovernment policy$zUnited States
606   $aMedical protocols$xGovernment policy$zUnited States
615  0$aConsultants$xGovernment policy
615  0$aClinical trials$xGovernment policy
615  0$aMedical protocols$xGovernment policy
712 02$aCenter for Biologics Evaluation and Research (U.S.)
712 02$aCenter for Drug Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910701998203321
996   $aGuidance for industry$93434577
997   $aUNINA